Sensitivity of Contrast-Enhanced Breast MRI vs X-ray Mammography Based on Cancer Histology, Tumor Grading, Receptor Status, and Molecular Subtype: A Supplemental Analysis of 2 Large Phase III Studies.
Jan EndrikatGilda SchmidtDaniel HaverstockOlaf WeberZuzana Jirakova TrnkovaJörg BarkhausenPublished in: Breast cancer : basic and clinical research (2022)
ClinicalTrials.gov: NCT01067976 and NCT01104584.
Keyphrases
- contrast enhanced
- phase iii
- diffusion weighted
- magnetic resonance imaging
- open label
- dual energy
- magnetic resonance
- computed tomography
- clinical trial
- papillary thyroid
- diffusion weighted imaging
- phase ii
- double blind
- placebo controlled
- high resolution
- squamous cell
- single molecule
- mass spectrometry
- young adults
- binding protein